Literature DB >> 21192342

Prevalence of cardiovascular risk factors in an urban adult population from southern Spain. IMAP Study.

R Gomez-Huelgas1, J Mancera-Romero, M R Bernal-Lopez, S Jansen-Chaparro, A J Baca-Osorio, E Toledo, R Perez-Gonzalez, R Guijarro-Merino, F J Tinahones, M A Martinez-Gonzalez.   

Abstract

AIMS: To study the prevalence of cardiovascular risk factors in an urban population of Malaga, Spain and its relationship with educational level.
METHODS: A cross-sectional study was performed with a random representative sample of 2270 individuals from the adult population (18–80 years) from a specific Health-Care Centre in Malaga City. All participants underwent a clinical interview, including social-demographical information and a physical examination. A blood sample was also drawn.
RESULTS: The mean age of the participants was 43.6 ± 15.6 years and 57.6% had a low educational level. The prevalence of cardiovascular risk factors was: smoking 27.7%, hypertension 33.1%, diabetes 7.1% and dyslipidaemia 65.4%. Over 60% were either overweight or obese, and 76.7% had a sedentary lifestyle. Except for smoking and a low-HDL cholesterol, the prevalence of the other cardiovascular risk factors increased with age. A low educational level was associated with a high prevalence of cardiovascular risk factors, and this association was significant with regard to smoking, obesity, abdominal obesity and hypertriglyceridaemia.
CONCLUSIONS: The population studied presents a high prevalence of cardiovascular risk factors, especially dyslipidaemia and obesity. The low academic level was associated with an increased prevalence of smoking, obesity and dyslipidaemia. People with a low socio-cultural level are a priority target for introducing policies to prevent and control cardiovascular disease.

Entities:  

Mesh:

Year:  2011        PMID: 21192342     DOI: 10.1111/j.1742-1241.2010.02543.x

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


  6 in total

1.  Low rates of both lipid-lowering therapy use and achievement of low-density lipoprotein cholesterol targets in individuals at high-risk for cardiovascular disease across Europe.

Authors:  Julian P Halcox; Florence Tubach; Esther Lopez-Garcia; Guy De Backer; Claudio Borghi; Jean Dallongeville; Eliseo Guallar; Jesús Medina; Joep Perk; Ogün Sazova; Stephen Sweet; Carine Roy; José R Banegas; Fernando Rodriguez-Artalejo
Journal:  PLoS One       Date:  2015-02-18       Impact factor: 3.240

2.  The Gene-Diet Associations in Postmenopausal Women with Newly Diagnosed Dyslipidemia.

Authors:  B Grygiel-Górniak; E Kaczmarek; M Mosor; J Przysławski; J Nowak
Journal:  J Nutr Health Aging       Date:  2017       Impact factor: 4.075

3.  Differences among Sociodemographic Variables, Physical Fitness Levels, and Body Composition with Adherence to Regular Physical Activity in Older Adults from the EXERNET Multicenter Study.

Authors:  Fabio Jiménez-Zazo; Cristina Romero-Blanco; Esther Cabanillas; Asier Mañas; José A Casajús; Narcís Gusi; Eva Gesteiro; Marcela González-Gross; José-Gerardo Villa-Vicente; Luis Espino-Toron; Ignacio Ara; Susana Aznar
Journal:  Int J Environ Res Public Health       Date:  2022-03-24       Impact factor: 3.390

4.  Prevalence of obesity and associated cardiovascular risk: the DARIOS study.

Authors:  Francisco Javier Félix-Redondo; María Grau; José Miguel Baena-Díez; Irene R Dégano; Antonio Cabrera de León; Maria Jesús Guembe; María Teresa Alzamora; Tomás Vega-Alonso; Nicolás R Robles; Honorato Ortiz; Fernando Rigo; Eduardo Mayoral-Sanchez; Maria José Tormo; Antonio Segura-Fragoso; Daniel Fernández-Bergés
Journal:  BMC Public Health       Date:  2013-06-05       Impact factor: 3.295

5.  Association of HbA1c and cardiovascular and renal disease in an adult Mediterranean population.

Authors:  Domingo Hernandez; Ana Espejo-Gil; M Rosa Bernal-Lopez; Jose Mancera-Romero; Antonio J Baca-Osorio; Francisco J Tinahones; Ana M Armas-Padron; Pedro Ruiz-Esteban; Armando Torres; Ricardo Gomez-Huelgas
Journal:  BMC Nephrol       Date:  2013-07-17       Impact factor: 2.388

Review 6.  Impact of treatment with rosuvastatin and atorvastatin on cardiovascular outcomes: evidence from the Archimedes-simulated clinical trials.

Authors:  Furio Colivicchi; Catarina Sternhufvud; Sanjay K Gandhi
Journal:  Clinicoecon Outcomes Res       Date:  2015-11-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.